Back to Results
First PageMeta Content
Octreotide / Scintigraphy / Medicine / Neuroendocrine tumor / Octreotide scan


Title: OctreoScan® scintigraphy for gastro-entero-pancreatic (GEP) neuroendocrine tumours August 1999 Agency: Medicare Services Advisory Committee (MSAC) Commonwealth Department of Health and Age ing GPO Box 9848 Canber
Add to Reading List

Document Date: 2014-08-07 23:58:25


Open Document

File Size: 19,34 KB

Share Result on Facebook

Company

Mallinckrodt / /

Country

Australia / /

IndustryTerm

biochemical and conventional imaging / equivocal structural imaging / technology / /

MedicalCondition

neuroendocrine tumours / extrapancreatic tumours / further metastatic disease / surgically amenable disease / insulinomas / tumour / tumours / /

Organization

Centre for Clinical Effectiveness / Internet and international health technology agency / Department of Health / Medicare Services Advisory Committee / /

Position

Governor / /

Product

OctreoScan / /

URL

http /

SocialTag